Multi-conformation 3D QSAR study of benzenesulfonyl-pyrazol-ester compounds and their analogs as cathepsin B inhibitors

Barrett, 1981, Methods Enzymol., 80, 535, 10.1016/S0076-6879(81)80043-2 Chapman, 1994, The role of thiol proteases in tissue injury and remodeling, Am. J. Respir. Crit. Care Med., 150, S155, 10.1164/ajrccm/150.6_Pt_2.S155 Rooprai, 1997, Proteases and their inhibitors in human brain tumours: a review, Anticancer Res., 17, 4151 Roberts, 1999, Cathepsins as effector proteases in hepatocyte apoptosis, Cell Biochem. Biophys., 30, 71, 10.1007/BF02737885 Giusti, 2008, Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles, Neoplasia, 10, 481, 10.1593/neo.08178 Gounaris, 2008, Live imaging of cysteine-cathepsin activity reveals dynamics of focal inflammation, angiogenesis, and polyp growth, PLoS One, 3, e2916, 10.1371/journal.pone.0002916 Ha, 2008, Cathepsin B is involved in the trafficking of TNF-alpha-containing vesicles to the plasma membrane in macrophages, J. Immunol., 181, 690, 10.4049/jimmunol.181.1.690 Haque, 2008, New insights into the roles of endolysosomal cathepsins in the pathogenesis of Alzheimer's disease: cathepsin inhibitors as potential therapeutics, CNS Neurol. Disord. Drug Targets, 7, 270, 10.2174/187152708784936653 Sandes, 2007, Cathepsin B is involved in the apoptosis intrinsic pathway induced by Bacillus Calmette-Guerin in transitional cancer cell lines, Int. J. Mol. Med., 20, 823 Lutgens, 2007, Cathepsin cysteine proteases in cardiovascular disease, FASEB J., 21, 3029, 10.1096/fj.06-7924com Hook, 2007, Cysteine protease inhibitors effectively reduce in vivo levels of brain beta-amyloid related to Alzheimer's disease, Biol. Chem., 388, 247 Downs, 2005, Cathepsins B and D activity and activity ratios in normal ovaries, benign ovarian neoplasms, and epithelial ovarian cancer, J. Soc. Gynecol. Invest., 12, 539, 10.1016/j.jsgi.2005.06.009 Vasiljeva, 2008, Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice, Oncogene, 27, 4191, 10.1038/onc.2008.59 Vasiljeva, 2006, Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer, Cancer Res., 66, 5242, 10.1158/0008-5472.CAN-05-4463 Jane, 2006, B localizes to plasma membrane caveolae of differentiating myoblasts and is secreted in an active form at physiological pH, Biol. Chem., 387, 223, 10.1515/BC.2006.030 Akache, 2007, A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8, Mol. Ther., 15, 330, 10.1038/sj.mt.6300053 Chandran, 2005, Endosomal proteolysis of the ebola virus glycoprotein is necessary for infection science, Science, 308, 1643, 10.1126/science.1110656 Simmons, 2005, Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry, Proc. Natl. Acad. Sci. U.S.A., 102, 11876, 10.1073/pnas.0505577102 Hook, 2008, Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein, J. Biol. Chem., 283, 7745, 10.1074/jbc.M708362200 Hosokawa, 2008, Over-expression of cysteine proteinase inhibitor cystatin 6 promotes pancreatic cancer growth, Cancer Sci., 99, 1626, 10.1111/j.1349-7006.2008.00869.x Parker, 2008, Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer, J. Pathol., 214, 337, 10.1002/path.2265 Yamamoto, 2000, Substrate specificity of bovine cathepsin B and its inhibition by CA074, based on crystal structure refinement of the complex, J. Biochem., 127, 635, 10.1093/oxfordjournals.jbchem.a022651 Greenspan, 2001, Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design, J. Med. Chem., 44, 4524, 10.1021/jm010206q Otto, 1997, vol. 97 Mladenovic, 2008, Atomistic insights into the inhibition of cysteine proteases: first QM/MM calculations clarifying the stereoselectivity of epoxide-based inhibitors, J. Phys. Chem. B, 112, 11798, 10.1021/jp803895f Redzynia, 2008, Displacement of the occluding loop by the parasite protein, chagasin, results in efficient inhibition of human cathepsin B, J. Biol. Chem., 283, 22815, 10.1074/jbc.M802064200 Watanabe, 2006, Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes, J. Mol. Biol., 362, 979, 10.1016/j.jmb.2006.07.070 Markt, 2008, Discovery of novel cathepsin S inhibitors by pharmacophore-based virtual high-throughput screening, J. Chem. Inf. Model., 48, 1693, 10.1021/ci800101j Beavers, 2008, Molecular docking of cathepsin L inhibitors in the binding site of papain, J. Chem. Inf. Model., 48, 1464, 10.1021/ci800085c Zhou, 2009, Computational analysis of the cathepsin B inhibitors activities through LR-MMPBSA binding affinity calculation based on docked complex, J. Comput. Chem., 30, 2165 Zhou, 2010, QSAR models for predicting cathepsin B inhibition by small molecules—continuous and binary QSAR models to classify cathepsin B inhibition activities of small molecules, J. Mol. Graph. Model., 28, 4, 10.1016/j.jmgm.2010.01.009 Hopfinger, 1997, Construction of 3D-QSAR models using the 4D-QSAR analysis formalism, J. Am. Chem. Soc., 119, 10509, 10.1021/ja9718937 Myers, 2007, Identification and characterization of 3-substituted pyrazolyl esters as alternate substrates for cathepsin B: the confounding effects of DTT and cysteine in biological assays, Bioorg. Med. Chem. Lett., 17, 4761, 10.1016/j.bmcl.2007.06.091 Jorgensen, 1988, The OPLS potential function for proteins energy minimizations for crystals of cyclic peptides and crambin, J. Am. Chem. Soc., 110, 1657, 10.1021/ja00214a001 Damm, 1997, OPLS all-atom force field for carbohydrates, J. Comput. Chem., 18, 1955, 10.1002/(SICI)1096-987X(199712)18:16<1955::AID-JCC1>3.0.CO;2-L Rizzo, 1999, OPLS all-atom model for amines: resolution of the amine hydration problem, J. Am. Chem. Soc., 121, 4827, 10.1021/ja984106u Jorgensen, 1996, Testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids, J. Am. Chem. Soc., 118, 11225, 10.1021/ja9621760 Friesner, 2004, Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy, J. Med. Chem., 47, 1739, 10.1021/jm0306430 Halgren, 2004, Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening, J. Med. Chem., 47, 1750, 10.1021/jm030644s Zhou, 2006, Structure modeling, ligand binding, and binding affinity calculation (LR-MM-PBSA) of human heparanase for inhibition and drug design, Proteins: Struct. Funct. Bioinf., 65, 580, 10.1002/prot.21065 Zhou, 2008, Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein, ACS Chem. Biol., 3, 765, 10.1021/cb800176t Zhou, 2004, CoMFA 3D-QSAR analysis of HIV-1 RT nonnucleoside inhibitors, TIBO derivatives based on docking conformation and alignment, J. Chem. Inf. Comput. Sci., 44, 2167, 10.1021/ci049893v